View All Key Stats
NSPR Key Stats
| Income Statement | |
| Revenue (TTM) | 2.00M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.44 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -8.724M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 22.97% |
| Profit Margin (Quarterly) | -358.4% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 3.017M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 0.9489 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.5254 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.00 |
| Free Cash Flow (Quarterly) | -1.601M |
| Return on Equity (TTM) | -234.1% |
View All NSPR News
NSPR News
-
WireHeadlineTime (ET)
-
MT Newswires10/12 11:28
-
Marketwired10/12 10:35
-
SA Breaking News10/09 15:33
-
MT Newswires10/09 12:01
-
Marketwired10/09 11:07
-
Marketwired10/04 09:02
-
SA Breaking News09/30 08:47
-
MT Newswires09/21 08:03
-
Marketwired09/21 02:01
-
Yahoo09/18 16:07
NSPR Fundamentals
Income Statement View Statement
NSPR Ratings
Advertisement
NSPR One Page Reports
- One Page Report Download
NSPR Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 0.4049 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.inspire-md.com
- Investor Relations URL: http://www.inspiremd.com/en/investors/investor-relations/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Medical Devices
- Equity Style: Small Cap/Value
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 05, 2015
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: InspireMD Inc is a medical device company. The Company is engaged in the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease.
NSPR Comparables
EditNSPR Excel Add-In Codes
- Name: =YCI("NSPR","name")
- Description: =YCI("NSPR","description")
- Sector: =YCI("NSPR","sector")
- Industry: =YCI("NSPR","industry")
- Est. Current Fiscal Year End: =YCI("NSPR","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other NSPR Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NSPR Tweets Stocktwits
Advertisement
